CV vs HAL · rev $3.5M vs P/E 9.3, $19.05B cap
CapsoVision, Inc. Common Stock (CV) versus Halliburton Company (HAL) — a side-by-side from cached financials, not a winner call.
CapsoVision, Inc. Common Stock (CV) is a medical devices company listed on US.
Halliburton Company (HAL) is a oil & gas equipment & services company listed on US.
Latest reported CV revenue for 2025-09-30 was $3.5M. Net income was -$7.9M. Revenue was up 6.7% from 2025-06-30 to 2025-09-30. CV currently screens at market cap $359.2M.
HAL does not have a complete income-statement cache yet.
CV currently screens at market cap $359.2M. HAL currently screens at market cap $19.05B and trailing P/E 9.3.
Not investment advice. Open the CV and HAL stock pages for the full models.
Not investment advice.